
In a recent study, researchers have discovered that patients with aspirin-exacerbated respiratory disease (AERD) have higher levels of IL-5, CCL2, and CXCL8 in their sinus mucous compared to aspirin-tolerant patients with chronic rhinosinusitis (CRS). These mediators play a crucial role in triggering widespread inflammatory responses that contribute to AERD. The findings highlight that AERD is not solely a type 2 (T2) disease but rather a heterogeneous condition, which may explain its resistance to treatment. This study sheds light on the complex nature of AERD and calls for further research to improve its management.
Like
Save
Share